Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma

Cancer

Volumn 79, Issue 1, 1997, Pages 81-89

  Crook, Juanita M ^a,c   Bahadur, Yasir A ^a   Robertson, Susan J ^b   Perry, Gad A ^a   Esche, Bernd A ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Department of Radiation Oncology ^*  (Canada)

Author keywords

external beam radiotherapy; postradiotherapy prostate biopsies; proliferative cell nuclear antigen; prostate carcinoma; prostate specific antigen nadir

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BEAM THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; RADIATION DOSE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031036150     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.0.CO;2-2     Document Type: Article

References (29)

1. Boring C, Squires T, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26.
2. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 1993;20:713-25.
3. Zietman AL, Shipley WU, Willett CG. Residual disease after radical surgery or radiation therapy for prostate cancer. Cancer Suppl 1993;71:959-69.
4. Zincke H, Oesterling JE, Blute ML, Bergstrahl EJ, Myers RP, Barrett DM. Long term (15 year) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850-7.
5. Forman JD, Oppenheim T, Liu H, Montie J, McLaughlin PW, Porter AT. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy. Prostate 1993;23:235-43.
6. Grignon DJ, Sakr WA. Histologic effects of radiation therapy and total androgen blockade on prostate cancer. Cancer Suppl 1995;75:1837-41.
7. Mahan DE, Bruce AW, Manley PN, Franchi L. Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy. J Urol 1980;124:488-91.
8. Stamey TA, Ferrari MK, Schmid HP. The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. J Urol 1993;150:1856-9.
9. Hermanek P, Sobin LH, editors. International Union Against Cancer. TNM classification of malignant tumours. 4th revised edition. Berlin: Springer-Verlag, 1987.
10. Brawer MK, Nagle RB, Pitts W, Freiha F, Gamble SL. Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates. Cancer 1989;63:454-60.
11. Bôcking A, Auffermann W. Cytological grading of therapy-induced tumor regression in prostatic carcinoma: proposal of a new system. Diagn Cytopathol 1987;3:108-11.
12. Cox JD, Kline RW. The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer. Semin Urol 1983;1:237-42.
13. Prestidge BR, Kaplan I, Cox RS, Bagshaw MA. Predictors of survival after a positive post-irradiation prostate biopsy. Int J Radiat Oncol Biol Phys 1994;28:17-22.
14. Crook J, Robertson S, Esche B. Proliferative cell nuclear antigen in post radiotherapy prostate biopsies. Int J Radiat Oncol Biol Phys 1994;30:303-8.
15. Crook JM, Perry GA, Robertson S, Esche BA. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology 1995;45:624-32.
16. Mostofi FK, Sesterhenn IA, Davis CJ Jr. A pathologist's view of prostatic carcinoma. Cancer Suppl 1993;71:906-32.
17. Dhom G, Degro S. Therapy of prostatic cancer and histopathologic follow-up. Prostate 1982;3:531-42.
18. Armas OA, Aprikian AG, Melamed J, Cordon-Cardo C, Cohen DW, Erlandson R, et al. Am J Surg Pathol 1994;18:979-91.
19. Mostofi FK, Davis CJ Jr., Sesterhenn IA. Pathology of carcinoma of the prostate. Cancer 1992;70:235-53.
20. Miller GJ, Cygan JM. Morphology of prostate cancer: the effects of multifocality on histologic grade, tumor volume and capsule penetration. J Urol 1994;152:1709-13.
21. Zietman AL, Coen JJ, Shipley WU, Willett CG, Efird JT. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen level as a predictor of treatment outcome. J Urol 1994;151:640-5.
22. Zelefsky MJ, Leibel SA, Wallner KE, Whitmore WF, Fuks Z. Significance of normal prostate specific antigen in the followup period after definitive radiation therapy for prostate cancer. J Clin Oncol 1995;13:459-63.
23. Stamey TA, Kabalin JN, Ferrari M. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. J Urol 1989;141:1084-7.
24. Grob BM, Schellhammer PE, Brassil DN, Wright GL. Changes in immunohistochemical staining of PSA, PAP and TURP-27 following irradiation therapy for clinically localized prostate cancer. Urology 1994;44:525-9.
25. Vernon SE, Williams WD. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostate specific antigen by immunohistochemistry. J Urol 1983;130: 95-8.
26. Miura M, Demon M, Sasaki T, Kondo S, Takasaki Y. Two types of proliferating cell nuclear antigen (PCNA) complex formation in quiescent normal and xeroderma pigmentosum group A fibroblasts following ultraviolet light (uv) irradiation. Exp Cell Res 1992;201:541-4.
27. Miura M, Domon M, Sasaki T, Takasaki Y. Induction of proliferating cell nuclear antigen (PCNA) complex formation in quiescent fibroblasts from a xeroderma pigmentosum patient. J Cell Physiol 1992;150:370-6.
28. Siders DB, Lee F. Histologic changes of irradiated prostatic carcinoma diagnosed by transrectal ultrasound. Hum Pathol 1992;23:344-51.
29. Wheeler JA, Zagars GK, Ayala AG. Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Cancer 1993;71:3783-7.